Skip to main content
Top
Literature
1.
go back to reference Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, Hillmen P, Ireland R, Kulasekararaj A, Mufti G, Snowden JA (2016) Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol 172(2):187–207CrossRefPubMed Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, Hillmen P, Ireland R, Kulasekararaj A, Mufti G, Snowden JA (2016) Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol 172(2):187–207CrossRefPubMed
2.
go back to reference Blennow O, Fjaertoft G, Winiarski J, Ljungman P, Mattsson J, Remberger M (2014) Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis the incidence remains high. Biol Blood Marrow Transpl 20(10):1646–1649CrossRef Blennow O, Fjaertoft G, Winiarski J, Ljungman P, Mattsson J, Remberger M (2014) Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis the incidence remains high. Biol Blood Marrow Transpl 20(10):1646–1649CrossRef
3.
go back to reference Leung J, Harpaz R, Baughman AL et al (2010) Evaluation of laboratory methods for diagnosis of varicella. Clin Infect Dis 51(1):23–32CrossRefPubMed Leung J, Harpaz R, Baughman AL et al (2010) Evaluation of laboratory methods for diagnosis of varicella. Clin Infect Dis 51(1):23–32CrossRefPubMed
Metadata
Title
Successful Stem Cell Transplantation from Varicella Infected Donor
Authors
Prerna Pramanik
Moupali Ghosh
Sumit Mitra
Bhaswati Bandopadhyay
Maitreyee Bhattacharyya
Publication date
25-04-2024
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-024-01738-6
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare